Elanco Animal Health (ELAN) Gross Margin (2017 - 2026)
Elanco Animal Health (ELAN) posted Gross Margin of 57.26% for Q1 2026, up 11.21% sequentially from 51.49% in Q4 2025, and down 8.0% YoY from 62.24% in Q1 2025.
Elanco Animal Health (ELAN) Gross Margin (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Gross Margin for 10 years, with the latest figure at 57.26% in Q1 2026.
- Quarterly Gross Margin fell 8.0% year-over-year to 57.26% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 55.06% (up 17.0% YoY) and the FY2025 annual result came in at 54.99%, up 12.0% from the prior year.
- Gross Margin grew to 57.26% in Q1 2026 per ELAN's latest filing, from 51.49% in the prior quarter.
- Over five years, Gross Margin peaked at 60.7% in Q1 2023 and troughed at 50.14% in Q4 2023.
- A 5-year average of 55.62% and a median of 57.26% in 2026 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2022 and 2023: Gross Margin soared 402 bps in 2022, then plunged 437 bps in 2023.
- Over 5 years, Gross Margin stood at 54.52% in 2022, then slipped by 8 bps to 50.14% in 2023, then climbed by 1 bps to 50.88% in 2024, then advanced by 1 bps to 51.49% in 2025, then gained by 11 bps to 57.26% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 57.26%, 51.49%, and 53.39% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 80.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58.33% |
| Mar 31, 2026 | 57.26% |
| Dec 31, 2025 | 51.49% |
| Sep 30, 2025 | 53.39% |
| Jun 30, 2025 | 57.45% |
| Mar 31, 2025 | 57.33% |
| Dec 31, 2024 | 50.88% |
| Sep 30, 2024 | 52.23% |
| Jun 30, 2024 | 58.19% |
| Mar 31, 2024 | 57.26% |
| Dec 31, 2023 | 50.14% |
| Sep 30, 2023 | 54.40% |
| Jun 30, 2023 | 58.94% |
| Mar 31, 2023 | 60.70% |
| Dec 31, 2022 | 54.52% |
| Sep 30, 2022 | 54.00% |
| Jun 30, 2022 | 58.81% |
| Mar 31, 2022 | 58.48% |
| Dec 31, 2021 | 54.14% |
| Sep 30, 2021 | 55.61% |